Moderna, Inc. CEO Stéphane Bancel hit just the right note when he introduced himself to the Senate Health Committee during what promised to be a tough hearing about the company’s decision to set a commercial price of $130 a dose for its SpikevaxCOVID-19 vaccine.
The French native began his testimony on 22 March by noting that he may “speak with an accent,” but he...







